Your browser doesn't support javascript.
loading
Prospective evaluation of hydrocortisone and suramin in patients with androgen-independent prostate cancer.
Kelly, W K; Curley, T; Leibretz, C; Dnistrian, A; Schwartz, M; Scher, H I.
Affiliation
  • Kelly WK; Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, NY 10021, USA.
J Clin Oncol ; 13(9): 2208-13, 1995 Sep.
Article in En | MEDLINE | ID: mdl-7545218
Subject(s)
Search on Google
Add to My VHL
Print
XML
PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Prostatic Neoplasms / Suramin / Testosterone / Hydrocortisone Type of study: Observational_studies / Risk_factors_studies Limits: Aged / Humans / Male / Middle aged Language: En Journal: J Clin Oncol Year: 1995 Document type: Article Affiliation country: Estados Unidos Country of publication: Estados Unidos
Search on Google
Add to My VHL
Print
XML
PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Prostatic Neoplasms / Suramin / Testosterone / Hydrocortisone Type of study: Observational_studies / Risk_factors_studies Limits: Aged / Humans / Male / Middle aged Language: En Journal: J Clin Oncol Year: 1995 Document type: Article Affiliation country: Estados Unidos Country of publication: Estados Unidos